Direct answer: Antidepressant-induced weight gain is one of the most common and distressing side effects of SSRIs, SNRIs, and especially mirtazapine — affecting 10–25% of users and averaging 2–5 kg over the first year of treatment. Psilocybin produces no weight gain and may improve metabolic health through its effects on serotonin signaling and inflammation. The 2021 Nature Medicine trial found no weight gain in the psilocybin group, while the escitalopram group showed modest weight gain. For people who have discontinued antidepressants due to weight gain, psilocybin represents a compelling weight-neutral alternative.
The Scale of Antidepressant Weight Gain
Weight gain is one of the most commonly reported and most distressing side effects of antidepressant medications. A 2018 study in BMJ analyzed data from 294,123 patients and found that antidepressant use was associated with a 21% increased risk of gaining 5% or more body weight over 10 years. The risk was highest for mirtazapine (Remeron), followed by paroxetine (Paxil), and was present but lower for SSRIs including sertraline and escitalopram.
The weight gain is not trivial. A 2019 meta-analysis in JAMA Psychiatry found that long-term antidepressant use (more than 2 years) was associated with an average weight gain of 2–5 kg, with some patients gaining 10 kg or more. For people who are already struggling with body image, metabolic health, or obesity-related conditions, this weight gain is not an acceptable trade-off — it is a reason to stop medication.
A 2020 survey of antidepressant users found that weight gain was the most commonly cited reason for discontinuing medication (cited by 31% of discontinuers), ahead of sexual dysfunction (28%) and emotional blunting (24%). The weight gain problem is not a minor inconvenience — it is a primary driver of the 50% antidepressant discontinuation rate within the first 3 months.
Why Antidepressants Cause Weight Gain
The mechanisms of antidepressant-induced weight gain are multiple and not fully understood, but several pathways have been identified. SSRIs increase serotonin availability, which initially suppresses appetite (serotonin is anorexigenic). However, with chronic use, the body adapts by downregulating serotonin receptors, reducing the appetite-suppressing effect while the metabolic effects of altered serotonin signaling persist. Additionally, SSRIs affect histamine receptors (particularly paroxetine), which directly stimulate appetite. The emotional blunting caused by SSRIs may also increase food-seeking behavior as a substitute for emotional regulation.
Psilocybin's Weight Profile: What the Data Shows
| Medication/Treatment | Average Weight Change (1 year) | % Gaining >5% Body Weight | Mechanism |
|---|---|---|---|
| Psilocybin | No change (Nature Medicine 2021) | Not reported; no signal | 5-HT2A agonism; no histamine effect |
| Mirtazapine (Remeron) | +3–5 kg | ~30% | Strong H1 antihistamine; appetite stimulation |
| Paroxetine (Paxil) | +2–4 kg | ~25% | H1 antihistamine + SERT inhibition |
| Sertraline (Zoloft) | +1–3 kg | ~15% | SERT inhibition; receptor adaptation |
| Escitalopram (Lexapro) | +1–2 kg | ~12% | SERT inhibition; receptor adaptation |
| Fluoxetine (Prozac) | 0–1 kg (short-term weight loss possible) | ~10% | SERT inhibition; initial appetite suppression |
| Venlafaxine (Effexor) | +1–3 kg | ~15% | SERT + NET inhibition |
Psilocybin and Metabolic Health: An Emerging Story
Beyond the absence of weight gain, there is emerging evidence that psilocybin may have positive metabolic effects. A 2022 study in Nature Medicine found that psilocybin reduced inflammatory markers (including IL-6 and TNF-alpha) in depressed patients — inflammation that is associated with insulin resistance and metabolic dysfunction. Additionally, psilocybin's effects on the serotonin system may improve gut motility and the gut-brain axis, which plays a significant role in metabolic health.
The neuroplasticity effects of psilocybin may also indirectly support metabolic health by improving sleep quality (poor sleep is strongly associated with weight gain and insulin resistance) and reducing stress (chronic stress promotes cortisol-driven fat accumulation, particularly visceral fat).
For People Who Have Gained Weight on Antidepressants
For people who have discontinued antidepressants due to weight gain, or who are considering discontinuation for this reason, psilocybin represents a weight-neutral alternative with superior efficacy on the outcomes that matter most. The 71% remission rate in the Johns Hopkins trials, combined with the absence of weight gain, sexual dysfunction, and emotional blunting, makes psilocybin a compelling option for people who have been unable to tolerate standard antidepressants.
According to Shrooomz's microdosing protocol, the Secret Shrooomz formula provides psilocybin in a sub-perceptual daily-compatible format that does not impair functioning and has no reported weight effects. The Lion's Mane component may additionally support metabolic health through its anti-inflammatory and gut microbiome effects.
For related reading: SSRI Withdrawal: Natural Alternatives, Psilocybin for Emotional Numbness, and Psilocybin vs Lexapro.
Frequently Asked Questions
Which antidepressant causes the most weight gain?
Mirtazapine (Remeron) causes the most weight gain, averaging 3–5 kg over the first year. Paroxetine (Paxil) is second. SSRIs like sertraline and escitalopram cause less weight gain but still affect 10–15% of users.
Does psilocybin cause weight gain?
No. Clinical trial data shows no weight gain with psilocybin. The 2021 Nature Medicine trial found no weight change in the psilocybin group over 6 weeks.
Can I lose the weight I gained on antidepressants after stopping?
Many people lose the antidepressant-induced weight after discontinuation, but the timeline varies. The weight gain is partly driven by receptor adaptation that reverses over months after stopping the medication.
Ready to experience the difference?
Shop Secret Shrooomz →